We are live on ! Find out more
Point72 Asset Management

Point72 Asset Management Portfolio holdings

AUM $78.1B
1-Year Est. Return 55.25%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19.5B
AUM Growth
+$4.2B
Cap. Flow
+$3.06B
Cap. Flow %
15.66%
Top 10 Hldgs %
15.97%
Holding
1,184
New
406
Increased
253
Reduced
226
Closed
288

Sector Composition

Rank Sector Weight
1 Healthcare 22.23%
2 Technology 20.39%
3 Consumer Discretionary 13.52%
4 Financials 8.95%
5 Communication Services 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSTK icon
751
Shutterstock
SSTK
$221M
$1.3M 0.01%
+25,045
New +$1.19M
QEP
752
DELISTED
QEP RESOURCES, INC.
QEP
$1.27M 0.01%
1,407,743
-122,757
-8% -$160K
DAR icon
753
Darling Ingredients
DAR
$9.56B
$1.27M 0.01%
+35,233
New +$1.08M
ARQT icon
754
Arcutis Biotherapeutics
ARQT
$3.26B
$1.27M 0.01%
+43,256
New +$1.16M
BSY icon
755
Bentley Systems
BSY
$11B
$1.26M 0.01%
+40,000
New +$1.29M
TMDX icon
756
Transmedics
TMDX
$2.79B
$1.24M 0.01%
90,009
+58,735
+188% +$1.01M
R icon
757
Ryder
R
$10.3B
$1.22M 0.01%
+28,974
New +$1.17M
BNY
758
Bank of New York Mellon
BNY
$106B
$1.21M 0.01%
35,311
-330,208
-90% -$12M
TIG
759
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$1.2M 0.01%
+78,839
New +$1.2M
VITL icon
760
Vital Farms
VITL
$521M
$1.2M 0.01%
+29,600
New +$1.12M
PLRX icon
761
Pliant Therapeutics
PLRX
$65M
$1.17M 0.01%
+51,500
New +$1.29M
GEO icon
762
CALL
The GEO Group
GEO
$4.18B
$1.13M 0.01%
100,000
AEIS icon
763
Advanced Energy
AEIS
$13.7B
$1.13M 0.01%
+17,900
New +$1.25M
EG icon
764
Everest Group
EG
$14.2B
$1.12M 0.01%
5,685
-128,432
-96% -$27.5M
CAN
765
Canaan Creative
CAN
$149M
$1.12M 0.01%
+600,000
New +$1.25M
ATHM icon
766
Autohome
ATHM
$2.64B
$1.12M 0.01%
+11,641
New +$1.01M
EMB icon
767
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$1.11M 0.01%
10,000
-210,000
-95% -$23.6M
IMAX icon
768
IMAX
IMAX
$2.81B
$1.09M 0.01%
+90,976
New +$1.18M
ATEX icon
769
Anterix
ATEX
$2.07B
$1.09M 0.01%
33,200
+13,500
+69% +$572K
RAMP icon
770
LiveRamp
RAMP
$2.3B
$1.08M 0.01%
+20,900
New +$1.04M
AZUL
771
DELISTED
Azul
AZUL
$1.08M 0.01%
+81,900
New +$1.05M
DK icon
772
Delek US
DK
$4.06B
$1.06M 0.01%
95,000
+42,533
+81% +$654K
RBAC.U
773
DELISTED
RedBall Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one
RBAC.U
$1.06M 0.01%
+100,000
New +$1.03M
FWONK icon
774
Liberty Media Series C
FWONK
$24.2B
$1.03M 0.01%
29,483
-189,339
-87% -$6.66M
INMB icon
775
INmune Bio
INMB
$50.8M
$1.03M 0.01%
+100,000
New +$1.02M

Similar funds

Point72 Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Point72 Asset Management held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Point72 Asset Management deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.

  • Point72 Asset Management's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
  • Point72 Asset Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
  • Point72 Asset Management's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
  • Point72 Asset Management fully exited Salesforce in Q3 2020, selling an estimated $105M.
  • Point72 Asset Management's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
  • Point72 Asset Management opened 406 new positions and closed 288 in Q3 2020.
  • Point72 Asset Management's portfolio value rose 27% quarter-over-quarter to $19.5B.

Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.